Evidence map›Paper›PMID 39384698›Full record

ArticleCell biochemistry and biophysics2025

Association Between Recurrence of High-grade Squamous Intraepithelial Lesions of the Uterine Cervix and p16, C-myc and PIK3CA Proteins-A Single-center Retrospective Study.

Ya Li, Rui Zhang, Jin Zhang, Ying Gao, Yawen Bian, Wenpei Bai

Abstract read
PubMed Publisher
In one paragraph

Article in Cell biochemistry and biophysics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ya LiThe Department of Gynecology and Obstetrics, Beijing Shijitan Hospital, Capital Medical University, Haidian, 100038, Beijing, China.
Rui ZhangThe Department of Gynecology and Obstetrics, Beijing Shijitan Hospital, Capital Medical University, Haidian, 100038, Beijing, China.
Jin ZhangThe Department of Gynecology and Obstetrics, Beijing Shijitan Hospital, Capital Medical University, Haidian, 100038, Beijing, China.
Ying GaoThe Department of Pathology, Beijing Shijitan Hospital, Capital Medical University, Haidian, 100038, Beijing, China.
Yawen BianThe Department of Pathology, Beijing Shijitan Hospital, Capital Medical University, Haidian, 100038, Beijing, China.
Wenpei BaiThe Department of Gynecology and Obstetrics, Beijing Shijitan Hospital, Capital Medical University, Haidian, 100038, Beijing, China. baiwp@bjsjth.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cervical high-grade squamous intraepithelial lesions (HSIL) are one of the common types of cervical cancer precancerous changes, and HPV16/18 positivity is a risk factor for HSIL recurrence. By detecting the expression of relevant markers in the lesion tissue of recurrent patients, it is helpful for the diagnosis of HPV16/18 positivity and can provide a basis for disease recurrence risk assessment. Therefore, this study analyzed the relationship between p16, C-myc, PIK3CA proteins and HPV16/18 positivity in recurrent cervical HSIL patients. By examining the p16, C-myc, and PIK3CA proteins in the cervical lesion tissue of 180 HSIL recurrent patients who underwent examination in the hospital from January 2020 to December 2022, this study analyzed the relationship between p16, C-myc, and PIK3CA proteins and HPV16/18 positivity. PIK3CA expression detection found that the proportion of positive expression of p16, C-myc, and PIK3CA in HPV16/18 (+) patients was significantly higher than that in HPV16/18 (-), and the expression of HPV16/18 in HSIL patients was significantly positively correlated with p16, C-myc, and PIK3CA. Meanwhile, a prediction model F was constructed based on binary logistic regression analysis data with good fit, and through ROC curve analysis. It was found that p16, C-myc, PIK3CA, and logistic model F can effectively predict HPV16/18 (+), with model F having the best diagnostic performance.

Indexed as

Class I Phosphatidylinositol 3-KinasesCyclin-Dependent Kinase Inhibitor p16Neoplasm Recurrence, LocalProto-Oncogene Proteins c-mycSquamous Intraepithelial LesionsUterine Cervical NeoplasmsAdultFemaleHuman papillomavirus 16Human papillomavirus 18HumansMiddle AgedPapillomavirus InfectionsRetrospective StudiesCDKN2A protein, humanClass I Phosphatidylinositol 3-KinasesCyclin-Dependent Kinase Inhibitor p16MYC protein, humanPIK3CA protein, humanProto-Oncogene Proteins c-mycCervical lesion tissuesC-mycDisease recurrenceHigh-grade squamous intraepithelial lesionHPV16/18 positivityp16PIK3CA

Identifiers

PMID39384698

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.